| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6110671 | Pancreatology | 2015 | 6 Pages |
Abstract
Impact of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma is currently understudied in the available literature. Definitive association between cachexia and survival cannot be drawn from available studies, although weight loss and sarcopenic obesity might be considered as poor prognostic factors. Further prospective trials utilizing the consensus definition of cachexia and including other confounding factors are needed to investigate the impact of cachexia and sarcopenia on survival in pancreatic adenocarcinoma.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
I. Ozola Zalite, R. Zykus, M. Francisco Gonzalez, F. Saygili, A. Pukitis, S. Gaujoux, R.M. Charnley, V. Lyadov,